The Cell Sciences Imaging Facility (CSIF) Shared Resource provides access to and training in high resolution, state-of-the-art imaging technologies. These technologies are essential tools for studying the molecular, sub-cellular and cellular mechanisms of cancer The CSIF is organized into three interdependent resources: the Fluorescence Microscopy Core (FMC), the Electron Microscopy Core (EMC) and the Array Tomography Core (ATC). The facility's FMC houses three advanced imaging systems that provide confocal, deconvolution, and 2-photon fluorescent light microscopy technologies for imaging both fixed and live cells and tissues. The Facility's EMC offers complete sample preparation and training in both transmission and scanning electron microscopy technologies for ultra structural and immunohistochemical studies. The Facility's ATC provides complete array tomography services, from array generation and labeling to automated imaging of immunolocalized arrays. Additional equipment includes all ancillary equipment necessary for sample preparation and advanced software resources for 3D, 4D interactive volume imaging of data sets, as well as advanced deconvolution software packages. The CSIF's current operating budget is approximately $500,000. The CSIF recovers, on average, 84% of this cost through user fees with the remaining 16% covered by the Cancer Center and institutional funds. Additionally, institutional funds support the growth of the CSIF by funding capital equipment needs not easily funded through grants. Leadership is provided by the CSIF's Advisory Committee. This nine member committee includes Dr. Stephen Smith, a world expert in microscopy, Mr. Mulholland, Director of the CSIF, and seven researchers from the Cancer Center, School of Medicine and School of the Humanities and Sciences. Forty-six Cancer Center members currently use the CSIF resources. Future goals of the CSIF include providing improved live cell and tissue imaging technologies. The CSIF also continues to actively develop its cryo and immuno-EM technologies and is developing correlative methods for light and electron microscopy, all of which will be essential to the study and understanding of the molecular and structural basis of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-07
Application #
8475460
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
7
Fiscal Year
2013
Total Cost
$56,585
Indirect Cost
$4
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Banerjee, Imon; Gensheimer, Michael Francis; Wood, Douglas J et al. (2018) Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Sci Rep 8:10037
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15

Showing the most recent 10 out of 322 publications